Edap Tms SA
NASDAQ:EDAP
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Edap Tms SA
Total Equity
Edap Tms SA
Total Equity Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Total Equity | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Edap Tms SA
NASDAQ:EDAP
|
Total Equity
€23.3m
|
CAGR 3-Years
-32%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
4%
|
|
|
Biomerieux SA
PAR:BIM
|
Total Equity
€4.1B
|
CAGR 3-Years
4%
|
CAGR 5-Years
11%
|
CAGR 10-Years
11%
|
|
|
Diagnostic Medical Systems SA
PAR:ALDMS
|
Total Equity
€12.8m
|
CAGR 3-Years
-12%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
N/A
|
|
|
S
|
SMAIO SA
PAR:ALSMA
|
Total Equity
€6.8m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
31%
|
CAGR 10-Years
N/A
|
|
|
Amplitude Surgical SA
PAR:AMPLI
|
Total Equity
€94.7m
|
CAGR 3-Years
19%
|
CAGR 5-Years
1%
|
CAGR 10-Years
N/A
|
|
|
Mauna Kea Technologies SA
PAR:ALMKT
|
Total Equity
-€29.4m
|
CAGR 3-Years
-23%
|
CAGR 5-Years
-37%
|
CAGR 10-Years
N/A
|
|
Edap Tms SA
Glance View
EDAP TMS SA is a holding company, which through its subsidiary engages in the development, production, and marketing of minimally invasive medical devices for urological diseases. The company is headquartered in Vaulx-En-Velin, Auvergne-Rhone-Alpes and currently employs 227 full-time employees. The firm operates worldwide via an extensive network of corporate offices, subsidiaries and distribution partners. The firm invests in Research & Development, partnering with INSERM French public laboratory and international medical research institutions. Company's activity is organized in two divisions: HIFU and UDS (including lithotripsy activities). The firm is developing HIFU technology (High Intensity Focused Ultrasound) in non-invasive treatment of prostate conditions with its range of Robotic HIFU devices, Ablatherm Fusion and Focal One. The firm is also developing ESWL (Extracorporeal ShockWave Lithotripsy) and Stone Laser that offers a range of minimally invasive solutions covering the full scope of urinary tract stone indications.
See Also
What is Edap Tms SA's Total Equity?
Total Equity
23.3m
EUR
Based on the financial report for Sep 30, 2025, Edap Tms SA's Total Equity amounts to 23.3m EUR.
What is Edap Tms SA's Total Equity growth rate?
Total Equity CAGR 10Y
4%
Over the last year, the Total Equity growth was -45%. The average annual Total Equity growth rates for Edap Tms SA have been -32% over the past three years , -1% over the past five years , and 4% over the past ten years .
